Advertisement

Topics

Corvidia CEO Davidson Moves to CSO, de Garidel Named Chief Executive

18:44 EDT 4 Apr 2018 | Xconomy

Corvidia Therapeutics’ CEO Michael Davidson is taking a new role at the company as its chief scientific officer. Waltham, MA-based Corvidia has appointed Marc de Garidel to succeed Davidson as chief executive. De Garidel’s experience includes six years as chairman and CEO of France-based Ipsen. Corvidia’s lead drug is in a Phase 2 study testing […]

Original Article: Corvidia CEO Davidson Moves to CSO, de Garidel Named Chief Executive

NEXT ARTICLE

More From BioPortfolio on "Corvidia CEO Davidson Moves to CSO, de Garidel Named Chief Executive"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...